CTEV
Claritev Corporation
NYSE: CTEV · HEALTHCARE · HEALTH INFORMATION SERVICES
$23.40
+3.22% today
Updated 2026-07-29
Market cap
$396.70M
P/E ratio
—
P/S ratio
0.41x
EPS (TTM)
$-16.14
Dividend yield
—
52W range
$12 – $74
Volume
0.1M
Claritev Corporation (CTEV) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$23.40
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.0B | $0.9B | $1.0B | $1.0B | $1.0B | $1.0B | $1.0B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 0.58% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -29.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.